Pine Pharmaceuticals, LLC: Drug Recall
Recall #D-0531-2023 · 03/27/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0531-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Pine Pharmaceuticals, LLC
- Status
- Terminated
- Date Initiated
- 03/27/2023
- Location
- Tonawanda, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 932 syringes
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Product Description
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1
Distribution Pattern
Nationwide in the USA
Other Recalls by Pine Pharmaceuticals, LLC
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
- Class II: Risk 10/02/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.